BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9435 related articles for article (PubMed ID: 10746166)

  • 1. Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters.
    Miyamoto M; Hirano K; Ichikawa H; Fukumori Y; Akine Y; Tokuuye K
    Biol Pharm Bull; 1999 Dec; 22(12):1331-40. PubMed ID: 10746166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy.
    Ichikawa H; Watanabe T; Tokumitsu H; Fukumori Y
    Curr Drug Deliv; 2007 Apr; 4(2):131-40. PubMed ID: 17456032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.
    Tokumitsu H; Ichikawa H; Fukumori Y
    Pharm Res; 1999 Dec; 16(12):1830-5. PubMed ID: 10644070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.
    Tokumitsu H; Ichikawa H; Fukumori Y; Block LH
    Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):838-42. PubMed ID: 10399838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor accumulation of gadolinium in lipid-nanoparticles intravenously injected for neutron-capture therapy of cancer.
    Watanabe T; Ichikawa H; Fukumori Y
    Eur J Pharm Biopharm; 2002 Sep; 54(2):119-24. PubMed ID: 12191681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and preparation of gadolinium-reservoir microcapsules for neutron-capture therapy by means of the Wurster process.
    Miyamoto M; Ichikawa H; Fukumori Y; Akine Y; Tokuuye K
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2043-50. PubMed ID: 9433776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.
    Le UM; Cui Z
    Int J Pharm; 2006 Apr; 312(1-2):105-12. PubMed ID: 16457973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy.
    Dierling AM; Sloat BR; Cui Z
    Eur J Pharm Biopharm; 2006 Apr; 62(3):275-81. PubMed ID: 16274979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy.
    Saha TK; Ichikawa H; Fukumori Y
    Carbohydr Res; 2006 Dec; 341(17):2835-41. PubMed ID: 17045253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy.
    Jono K; Ichikawa H; Fujioka K; Fukumori Y; Akine Y; Tokuuye K
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):54-63. PubMed ID: 9987827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
    Shikata F; Tokumitsu H; Ichikawa H; Fukumori Y
    Eur J Pharm Biopharm; 2002 Jan; 53(1):57-63. PubMed ID: 11777753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy.
    De Stasio G; Casalbore P; Pallini R; Gilbert B; Sanità F; Ciotti MT; Rosi G; Festinesi A; Larocca LM; Rinelli A; Perret D; Mogk DW; Perfetti P; Mehta MP; Mercanti D
    Cancer Res; 2001 May; 61(10):4272-7. PubMed ID: 11358855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy.
    Le UM; Cui Z
    Int J Pharm; 2006 Aug; 320(1-2):96-103. PubMed ID: 16713149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Calcium Phosphate-Polymeric Micelles Incorporating Gadolinium Chelates for Imaging-Guided Gadolinium Neutron Capture Tumor Therapy.
    Mi P; Dewi N; Yanagie H; Kokuryo D; Suzuki M; Sakurai Y; Li Y; Aoki I; Ono K; Takahashi H; Cabral H; Nishiyama N; Kataoka K
    ACS Nano; 2015 Jun; 9(6):5913-21. PubMed ID: 26033034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
    De Stasio G; Rajesh D; Casalbore P; Daniels MJ; Erhardt RJ; Frazer BH; Wiese LM; Richter KL; Sonderegger BR; Gilbert B; Schaub S; Cannara RJ; Crawford JF; Gilles MK; Tyliszczak T; Fowler JF; Larocca LM; Howard SP; Mercanti D; Mehta MP; Pallini R
    Neurol Res; 2005 Jun; 27(4):387-98. PubMed ID: 15949236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
    Deagostino A; Protti N; Alberti D; Boggio P; Bortolussi S; Altieri S; Crich SG
    Future Med Chem; 2016 May; 8(8):899-917. PubMed ID: 27195428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-loaded chitosan nanoparticles for neutron-capture therapy: Influence of micrometric properties of the nanoparticles on tumor-killing effect.
    Ichikawa H; Uneme T; Andoh T; Arita Y; Fujimoto T; Suzuki M; Sakurai Y; Shinto H; Fukasawa T; Fujii F; Fukumori Y
    Appl Radiat Isot; 2014 Jun; 88():109-13. PubMed ID: 24462286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
    Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
    Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
    Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI.
    Kobayashi H; Kawamoto S; Saga T; Sato N; Ishimori T; Konishi J; Ono K; Togashi K; Brechbiel MW
    Bioconjug Chem; 2001; 12(4):587-93. PubMed ID: 11459464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 472.